SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-160743
Filing Date
2024-06-13
Accepted
2024-06-13 16:31:36
Documents
19
Period of Report
2024-04-03
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d814270d8ka.htm   iXBRL 8-K/A 38870
2 EX-23.1 d814270dex231.htm EX-23.1 3672
3 EX-99.2 d814270dex992.htm EX-99.2 85084
4 EX-99.5 d814270dex995.htm EX-99.5 164932
9 GRAPHIC g814270g36p63.jpg GRAPHIC 2627
10 GRAPHIC g814270g74o58.jpg GRAPHIC 2649
  Complete submission text file 0001193125-24-160743.txt   500016

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xoma-20240403.xsd EX-101.SCH 3869
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20240403_def.xml EX-101.DEF 14504
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20240403_lab.xml EX-101.LAB 24201
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20240403_pre.xml EX-101.PRE 15602
23 EXTRACTED XBRL INSTANCE DOCUMENT d814270d8ka_htm.xml XML 8372
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39801 | Film No.: 241041701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)